Q4 2025 Management View Thomas Polen, President, CEO & Chairman, reported that "Q4 revenue of $5.9 billion increased 7% and 3.9% organic. New BD delivered strong organic growth of 4.9%, accelerating ...

Q4 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAdam ReiffeThomas Polen - President, CEO ...

Becton Dickinson posts Q4 earnings beat, raises FY26 EPS outlook, with strong growth in Medical and Interventional segments ...

Becton Dickinson (NYSE:BDX) has had a rough week with its share price down 3.5%. It is possible that the markets ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2025 fourth quarter and full year, which ended September 30, 2025.

FRANKLIN LAKES, N.J. (AP) — FRANKLIN LAKES, N.J. (AP) — Becton Dickinson and Co. (BDX) on Thursday reported fiscal fourth-quarter profit of $493 million. The Franklin Lakes, New Jersey-based company ...

Becton Dickinson (BDX) came out with quarterly earnings of $3.96 per share, beating the Zacks Consensus Estimate of $3.92 per share. This compares to earnings of $3.81 per share a year ago. These ...

The panels employ PCR techniques to test for numerous gastrointestinal bacterial pathogens using one stool swab.

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second ...

Contribute to quality assurance initiatives by collaborating with engineering teams, implementing process improvements, and enhancing product quality metrics to achieve regulatory compliance and ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned -5.78% in the ...

Becton Dickinson & Co. closed 30.00% below its 52-week high of $251.99, which the company reached on February 3rd.